Citius Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $155 | $155 |
Gross Profit | -41 | -56 | -54 | -53 |
EBITDA | -8,726 | -11,191 | -9,984 | -10,996 |
EBIT | -8,767 | -11,247 | -10,039 | -11,050 |
Net Income | -8,789 | -10,916 | -9,768 | -10,790 |
Net Change In Cash | 0 | 0 | 155 | 155 |
Free Cash Flow | -5,406 | -4,539 | -4,725 | -5,912 |
Cash | 6,089 | 26 | 1,100 | 3,251 |
Basic Shares | 11,006 | 11,590 | 11,590 | 11,590 |
Annual Financials
| Values in thousands | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -209 | -194 | -179 | -164 |
EBITDA | -38,640 | -31,772 | -32,884 | -22,878 |
EBIT | -38,849 | -31,966 | -33,064 | -23,043 |
Net Income | -39,138 | -32,542 | -33,640 | -23,125 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -28,361 | 56,213 | ||
Free Cash Flow | -28,201 | -29,060 | -28,361 | -64,257 |
Cash | 3,251 | 26,480 | 41,711 | 70,072 |
Basic Shares | 11,590 | 10,086 | 9,738 | 7,239 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.80 |
2025-03-31 | -$1.27 |
2024-12-31 | -$1.30 |
2024-09-30 | -$1.58 |
